GoodRx (GDRX) ebitda was $249M in FY2025 (+6% YoY). The tables below show the complete quarterly and annual ebitda history, sourced from SEC EDGAR 10-K and 10-Q filings.
Annual EBITDA
Fiscal Year
EBITDA
YoY
2025
$249M
+6%
2024
$234M
+26%
2023
$185M
+5%
2022
$176M
-15%
2021
$208M
+49%
2020
$140M
-11%
2019
$157M
+77%
2018
$89M
Recent Quarterly EBITDA
Quarter
EBITDA
Q2 2026
$62M
Q1 2026
$52M
Q4 2025
$64M
Q3 2025
$54M
Q2 2025
$68M
Q1 2025
$63M
Q4 2024
$58M
Q3 2024
$64M
Q2 2024
$63M
Q1 2024
$48M
Q4 2023
$54M
Q3 2023
$27M
Source: GDRX on EDGAR. Data from SEC EDGAR 10-K and 10-Q filings. Updated quarterly.